Our capture compound mass spectrometry (CCMS) target identification technology facilitates the identification, optimization, and development to market of bioactive small molecules and the development of protein biomarkers, thus reducing risk and cost for our clients.

Ask Us About CCMS »

CCMS is based on:

  • Trifunctional molecules – Capture Compounds®
  • Chemistry knowhow for tailored design
  • Proprietary work flow
  • No solid matrix, in solution application
  • Specificity controls
  • Covalent crosslinking for high sensitivity

CCMS delivers a ranked short list of specific protein interactors for any small molecule. Watch the video to learn more.

You may also be interested in...

Target Discovery & Validation

Target Discovery & Validation

By combining proprietary adenoviral technology with complex cellular assays, Charles River’s target discovery group has delivered novel, validated drug targets in a range of therapeutic areas for over 10 years.

flask in scientist hand with test tube in rack

Integrated Drug Discovery

We utilize a truly integrated approach to small molecule dug discovery, uniting all of the key disciplines required to achieve a program's goals in a single project team.